Local Institution - 060 — North Massapequa, New York

Local Institution - 060 is a clinical research site located in North Massapequa, New York, United States 11758-1802.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 060 has participated in 3 clinical trials.

Therapeutic areas: Crohn Disease.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Massapequa

Browse all research sites in New York · View every site in North Massapequa

• DiGiovanna Institute for Medical Education & Research
• GSK Investigational Site
• DiGiovanna Institute for Medical Education and Research
• Novo Nordisk Investigational Site
• DiGiovanna Inst for Med Ed&Res
• DiGiovanna Family Care Center
• Research Site
• Synergy Research Site
• Digiovanna Institute For Medical Education
• Teva Investigational Site 13083
• Protagonist Investigational Site
• Duplicate_DiGiovanna Institute for Medical Education & Research /ID# 171126

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 060?

Local Institution - 060 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 060 conducted?

Local Institution - 060 has 3 clinical trials on record. Their work covers Crohn Disease.

Is Local Institution - 060 accredited by Crixeo Clinical Trials?

Local Institution - 060 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 060?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.